| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |